As of 2025-05-15, the Intrinsic Value of XORTX Therapeutics Inc (XRX.CN) is - CAD. This XRX.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.90 CAD, the upside of XORTX Therapeutics Inc is -100.00%.
Based on its market price of 1.90 CAD and our intrinsic valuation, XORTX Therapeutics Inc (XRX.CN) is overvalued by 100.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | - - - | - | -100.00% |
| P/E | (0.03) - (1.71) | (0.03) | -101.8% |
| DDM - Stable | (2.28) - (6.10) | (4.19) | -320.6% |
| DDM - Multi | (0.79) - (1.67) | (1.08) | -156.7% |
| Market Cap (mil) | 18.48 |
| Beta | 0.10 |
| Outstanding shares (mil) | 9.73 |
| Enterprise Value (mil) | 13.34 |
| Market risk premium | 4.74% |
| Cost of Equity | 11.63% |
| Cost of Debt | 5.00% |
| WACC | 7.65% |